Intravitreal methotrexate infusion for proliferative vitreoretinopathy

Abstract

Eyes at high risk for PVR development due to a history of prior PVR or intraocular inflammation had a low incidence of PVR following IMI at the time of PPV for RD repair. No significant safety issues from IMI were observed in this series.